Immuron Ltd — Regulatory Filings 2006

May 28, 2006

May 29th, 2006

Company Announcement Office Australian Stock Exchange Ltd (ASX) 4^th Floor, 20 Bridge Street Sydney NSW 2000

Dear Sir/Madam

Please find herewith a company announcement "Share Placement"" for release and distribution to the market immediately.

Yours sincerely

CONOR GRAHAM Managing Director & CEO

ANADIS LIMITED SHARE PLACEMENT

The Board of Directors of Anadis Limited are pleased to advise that the Company has raised funds in a share placement of \$1.7 million before costs. The placement represents 6.5% of the total current shares on issue. The placement comprised 2,500,000 fully paid ordinary shares in the capital of the Company at 28 cents per share to Australian professional investors, and an additional 3,448,276 fully paid ordinary shares at 29 cents per share to an overseas institution, with 862,069 attaching options. The options have a twelve month expiry date from date of issue and an exercise price of 38 cents per option..

This placement to institutional and professional investors has been partially arranged through Intersuisse Corporate. The majority of shares have been placed to Whitney $\&$ Co, an existing institutional shareholder.

The funds raised are to be utilized for the commercial scale-up of the Enterovirus 71 program and the continued international expansion of Travelan. Key Company executives will be traveling during June to the U.S.A, Canada, Taiwan and Singapore to further these objectives.

For Further information please contact:

Conor Graham - Managing Director $\&$ CEO or. Arie Nudel - Investor Relations

Telephone: 03 9358 6388 Facsimile: 03 9358 6399